142 related articles for article (PubMed ID: 13506569)
1. A study of the in vitro and in vivo effects of a synthetic heparin-like anticoagulant: dextran sulphate.
HJORT P; STORMORKEN H; GILJE O
Scand J Clin Lab Invest; 1957; 9 Suppl 29():1-86. PubMed ID: 13506569
[No Abstract] [Full Text] [Related]
2. The anticoagulant activity of dextran sulphate. I. An in vitro comparison between the actions of dextran sulphate and heparin on the various stages of blood coagulation.
FORWELL GD; INGRAM GI
J Pharm Pharmacol; 1956 Jul; 8(7):530-45. PubMed ID: 13346452
[No Abstract] [Full Text] [Related]
3. Heparinoid and heparin; an investigation into the anticoagulant effect of the dextran sulphate dexulate.
ARGE E
Acta Med Scand; 1956 Nov; 155(6):469-74. PubMed ID: 13372201
[No Abstract] [Full Text] [Related]
4. In vivo and in vitro comparative assays of the anticoagulant activity of dextran sulphate and heparin.
GRASSET E; SCHWARTZ DE
Br J Pharmacol Chemother; 1955 Sep; 10(3):317-20. PubMed ID: 13269707
[No Abstract] [Full Text] [Related]
5. [Heparinoid and heparin; anticoagulant effects of dexulate, a dextran sulfate preparation].
ARGE E
Ugeskr Laeger; 1957 Feb; 119(9):248-51. PubMed ID: 13422709
[No Abstract] [Full Text] [Related]
6. Vascular effects of heparin, dextran sulphate, and 5-hydroxytryptamine.
LAMBERT HP
Clin Sci; 1958 Nov; 17(4):621-8. PubMed ID: 13608972
[No Abstract] [Full Text] [Related]
7. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro.
Baba M; Pauwels R; Balzarini J; Arnout J; Desmyter J; De Clercq E
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6132-6. PubMed ID: 2457906
[TBL] [Abstract][Full Text] [Related]
8. [The toxicity of dextran sulfate, a synthetic anticoagulant of the heparin type].
SASAKI S; TAKEMOTO T; OKA S
C R Seances Soc Biol Fil; 1957; 151(10):1799-803. PubMed ID: 13547622
[No Abstract] [Full Text] [Related]
9. Therapeutic trial of the synthetic heparin analogue dextran sulphate.
RICKETTS CR; WALTON KW; VAN LEUVEN BD; BIRBECK A; BROWN A; KENNEDY AC; BURT CC
Lancet; 1953 Nov; 265(6794):1004-10. PubMed ID: 13110037
[No Abstract] [Full Text] [Related]
10. The mechanism of the prolonged bleeding time provoked by dextran sulphate or by excessive doses of heparin.
BORCHGREVINK CF
Acta Med Scand; 1961 Sep; 170():365-73. PubMed ID: 13871206
[No Abstract] [Full Text] [Related]
11. [Inhibitory effects of heparin and dextran sulfate alone and combined with ACTH and cortisone, on the coagulant action of viper venoms].
GRASSET E; SCHWARTZ DE
Bull Schweiz Akad Med Wiss; 1955 May; 11(1-2):10-22. PubMed ID: 14389908
[No Abstract] [Full Text] [Related]
12. The anticoagulant activity of dextran sulphate. II. The effect of dextran sulphate on the one-stage prothrombin time.
INGRAM GI; FORWELL GD
J Pharm Pharmacol; 1956 Aug; 8(8):589-601. PubMed ID: 13346455
[No Abstract] [Full Text] [Related]
13. [Inactivating property of various substances against the anticoagulant effect of heparin & dextran sulfate].
AGOLINI G
Boll Soc Ital Biol Sper; 1957 Jun; 33(6):874-6. PubMed ID: 13499727
[No Abstract] [Full Text] [Related]
14. Dextran sulphate: use as an anticoagulant, and action in lowering serum cholesterol.
COHEN H; TUDHOPE GR
Br Med J; 1956 Nov; 2(5000):1023-7. PubMed ID: 13364378
[No Abstract] [Full Text] [Related]
15. The biological behaviour of a new synthetic anticoagulant (dextran sulphate) possessing heparin-like properties.
WALTON KW
Br J Pharmacol Chemother; 1952 Sep; 7(3):370-91. PubMed ID: 12978241
[No Abstract] [Full Text] [Related]
16. Effects of heparin and dextran sulphate on the production of collagen and protein in diabetic and non-diabetic human skin fibroblast cultures.
Kjellström T; Malmquist J
Med Biol; 1983 Jun; 61(3):186-90. PubMed ID: 6195494
[TBL] [Abstract][Full Text] [Related]
17. Chronic toxicity of dextran sulphate in rabbits.
HINT HC; RICHTER AW
Br J Pharmacol Chemother; 1958 Jun; 13(2):109-12. PubMed ID: 13536272
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro.
Ito M; Baba M; Sato A; Pauwels R; De Clercq E; Shigeta S
Antiviral Res; 1987 Jul; 7(6):361-7. PubMed ID: 2445284
[TBL] [Abstract][Full Text] [Related]
19. [On the isolation of a fraction of serum lipoproteins after precipitation by heparin or by synthetic heparinoids].
Burstein M
C R Hebd Seances Acad Sci; 1956 Jul; 243(5):527-9. PubMed ID: 13365134
[No Abstract] [Full Text] [Related]
20. The autoactivation of factor XII (Hageman factor) induced by low-Mr heparin and dextran sulphate. The effect of the Mr of the activating polyanion.
Silverberg M; Diehl SV
Biochem J; 1987 Dec; 248(3):715-20. PubMed ID: 2449171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
